Biotech Company Thrives on Oracle

 
 
By eweek  |  Posted 2004-02-06 Email Print this article Print
 
 
 
 
 
 
 

Oracle is investing in Prolexy, a biotechnology firm it cofounded with Hitachi, amongst others, in 2001. The fit is good, not only because Oracle CEO Larry Ellison has a personal interest in biotech, but also because Oracle's technology is well-suited to

Oracle is investing in Prolexy, a biotechnology firm it cofounded with Hitachi, amongst others, in 2001. The fit is good, not only because Oracle CEO Larry Ellison has a personal interest in biotech, but also because Oracles technology is well-suited to the industry. For example, Oracles BLAST (basic local alignment search tool) is used to search for inter-species similarities in DNA sequences. Read the full story at Line56.
 
 
 
 
 
 
 
 
 
 
 

Submit a Comment

Loading Comments...
 
Manage your Newsletters: Login   Register My Newsletters























 
 
 
 
 
 
 
 
 
 
 
Thanks for your registration, follow us on our social networks to keep up-to-date
Rocket Fuel